Living with AS in United Kingdom
AS care in the UK is primarily NHS-funded. The key challenges are long rheumatology wait times, NICE approval criteria for biologics, and navigating GP referrals.
Getting a diagnosis
You need a GP referral to see an NHS rheumatologist. Use the term "inflammatory back pain" when speaking to your GP — it is more likely to trigger the right referral than general back pain.
NASS (National Axial Spondyloarthritis Society) has a GP referral guide you can print and bring to your appointment: nass.co.uk. The average diagnostic delay in the UK is 8.5 years.
Ask specifically about HLA-B27 testing and sacroiliac joint imaging (MRI or X-ray). Some GPs are not aware of NICE guidelines for axial spondyloarthritis.
Biologics and NICE criteria
NICE approves biologics for AS when conventional treatment (NSAIDs) has failed and BASDAI score is 4+ with clinical evidence of active disease. Your rheumatologist will assess this.
Approved biologics on the NHS include adalimumab (Humira/biosimilars), etanercept, certolizumab, golimumab, secukinumab, and ixekizumab. Biosimilars are widely prescribed and equally effective.
If your BASDAI is below 4 but you are still significantly affected, document functional impact carefully — the score is a guide, not an absolute threshold.
Benefits and financial support
AS may qualify you for Personal Independence Payment (PIP) based on daily living and mobility limitations, regardless of whether you are working.
If AS prevents you from working, you may be eligible for Employment and Support Allowance (ESA). Apply via GOV.UK.
The NASS benefits helpline can help you understand what you may be entitled to: nass.co.uk.
Workplace rights
AS is typically a disability under the Equality Act 2010. Your employer must make reasonable adjustments — flexible hours, remote work, ergonomic equipment, phased return after flare.
You are not required to disclose your specific diagnosis. "Inflammatory arthritis" is sufficient. Document all adjustment requests in writing.